76250
Off
S

Suraksha Diagnostic Ltd IPO

  • Status: Upcoming
  • - / - shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    06 Dec 2024

  • Listing Price

    ₹437.00

  • Listing Change

    -0.91%

  • Last Traded Price

    ₹412.15

IPO Details

  • Open Date

    TBA

  • Close Date

    TBA

  • IPO Price Range

    TBA

  • IPO Size

    TBA

  • Listing Exchange

    TBA

  • Listing Date

    TBA

With just a few clicks, Invest in IPOs!

+91

By proceeding, you agree to all T&C*

hero_form

Initial public offering of up to 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the Company or the Issuer) for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) (the Offer Price) aggregating up to Rs. [*] crores through an offer for sale of up to 19,189,330 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores, comprising up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Somnath Chatterjee, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Ritu Mittal, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the Promoter Selling Shareholders), up to 10,660,737 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Orbimed Asia ii Mauritius Limited^ (the Investor Selling Shareholder), up to 799,556 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Munna Lal Kejriwal, and up to 1,332,593 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Santosh Kumar Kejriwal (together the Individual Selling Shareholders) (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the Selling Shareholders, and such equity shares offered by the selling shareholders, the Offered Shares) (the Offer or the Offer for Sale). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. ^ Surviving entity pursuant to amalgamation of orbimed asia ii mauritius fdi investments limited, the erstwhile shareholder, into orbimed asia ii mauritius limited. The face value of the equity shares is Rs. 2 each and the offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be determined by the company.

Will You Apply for Suraksha Diagnostic Ltd IPO?

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form